Sugi Predict

Sugi Predict / Compounds / SCHEMBL1638340

SCHEMBL1638340

SCHEMBL1638340

CC(C)(C)OC(=O)NCCC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O

nearest known ligand 0.70

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ MDM2 Q00987 6/20 0.59
▸ KMT2A Q03164 1/20 0.53
▸ TLR2 O60603 3/20 0.51
▸ MDM4 O15151 2/20 0.51
▸ TP53 P04637 2/20 0.51
▸ TLR1 Q15399 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29397631 1.00 MDM2 (0.59) MDM2KMT2ATLR2MDM4TP53
SCHEMBL178814 1.00 MDM2 (0.59) MDM2KMT2ATLR2MDM4TP53
SCHEMBL1637300 1.00 MDM2 (0.59) MDM2KMT2ATLR2MDM4TP53
SCHEMBL29400055 1.00 MDM2 (0.59) MDM2KMT2ATLR2MDM4TP53
SCHEMBL30477936 1.00 MDM2 (0.59) MDM2KMT2ATLR2MDM4TP53
SCHEMBL2292778 0.97 MDM2 (0.59) MDM2KMT2ATLR2MDM4TP53
SCHEMBL29370147 0.97 MDM2 (0.59) MDM2KMT2ATLR2MDM4TP53
SCHEMBL2524769 0.97 MDM2 (0.59) MDM2KMT2ATLR2MDM4TP53
SCHEMBL1738182 0.97 MDM2 (0.59) MDM2KMT2ATLR2MDM4TP53
SCHEMBL29372236 0.97 MDM2 (0.59) MDM2KMT2ATLR2MDM4TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230146515-A1 MITOCHONDRIA-TARGETING PEPTIDES STEALTH BIOTHERAPEUTICS INC. 2023-05-11 — — US disclosed
CN-108699106-B Novel trifluoromethylpropionamide derivatives as HTRA1 inhibitors 豪夫迈·罗氏有限公司 2021-11-30 — — CN disclosed
US-11014963-B2 Trifluoromethylpropanamide derivatives as HTRA1 inhibitors HOFFMANN-LA ROCHE INC. (US) 2021-05-25 — — US disclosed
EP-3423469-A1 NEW TRIFLUOROMETHYLPROPANAMIDE DERIVATIVES AS HTRA1 INHIBITORS H. Hoffnabb-La Roche Ag (CH) 2019-01-09 — — EP disclosed
US-20180371016-A1 TRIFLUOROMETHYLPROPANAMIDE DERIVATIVES AS HTRA1 INHIBITORS HOFFMANN-LA ROCHE INC. (US) 2018-12-27 — — US disclosed
US-9309285-B2 Macrocyclic broad spectrum antibiotics RQX PHARMACEUTICALS, INC. (US) 2016-04-12 — — US disclosed
US-20160017000-A1 RGD-CONTAINING CYCLIC PEPTIDES UNIV CALIFORNIA (US) 2016-01-21 — — US disclosed
US-9073974-B2 RGD-containing cyclic peptides THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2015-07-07 — — US disclosed
WO-2014081886-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS RQX PHARMACEUTICALS, INC. (US) 2014-05-30 — — WO disclosed
US-20140142029-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS RQX PHARMACEUTICALS, INC. (US) 2014-05-22 — — US disclosed
WO-2008080223-A1 COMPOSITIONS AND METHODS FOR TREATING HYPERPROLIFERATIVE DISEASE MIGENIX INC. (CA) 2008-07-10 — — WO disclosed
EP-1910279-A2 NON-NUCLEOSIDE ANTI-HEPACIVIRUS AGENTS AND USES THEREOF MIGENIX INC. (CA) 2008-04-16 — — EP disclosed
US-7314726-B2 Beta secretase exosite binding peptides and methods for identifying beta secretase modulators BRISTOL-MYERS SQUIBB COMPANY (US) 2008-01-01 — — US disclosed
US-7314726-B2 Beta secretase exosite binding peptides and methods for identifying beta secretase modulators BRISTOL-MYERS SQUIBB COMPANY (US) 2008-01-01 — — US disclosed
US-20070208007-A1 Amine-Based Compound and Use Thereof KUREHA CORPORATION (JP) 2007-09-06 — — US disclosed
US-20070149763-A1 Beta secretase exosite binding peptides and methods for identifying beta secretase modulators BRISTOL-MYERS SQUIBB COMPANY 2007-06-28 — — US disclosed
US-20070149763-A1 Beta secretase exosite binding peptides and methods for identifying beta secretase modulators BRISTOL-MYERS SQUIBB COMPANY 2007-06-28 — — US disclosed
US-20070021434-A1 NON-NUCLEOSIDE ANTI-HEPACIVIRUS AGENTS AND USES THEREOF MIGENIX INC. (CA) 2007-01-25 — — US disclosed
WO-2007002639-A2 NON-NUCLEOSIDE ANTI-HEPACIVIRUS AGENTS AND USES THEREOF MIGENIX INC. (CA) 2007-01-04 — — WO disclosed
EP-1724263-A1 BASIC AMINE COMPOUND AND USE THEREOF Kureha Corporation (JP) 2006-11-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021434-A1 NON-NUCLEOSIDE ANTI-HEPACIVIRUS AGENTS AND USES THEREOF HAVCR2, ADAR, NSUN2 MDM2 3730/4885KMT2A 3406/4885TLR2 2757/4885
US-20140142029-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS MRPL21, PEPD, CTSC MDM2 1249/4885KMT2A 3283/4885TLR2 774/4885
US-11014963-B2 Trifluoromethylpropanamide derivatives as HTRA1 inhibitors HTRA1, HTR3E, HTR1F MDM2 3600/4885KMT2A 1252/4885TLR2 3697/4885
US-20180371016-A1 TRIFLUOROMETHYLPROPANAMIDE DERIVATIVES AS HTRA1 INHIBITORS HTRA1, HTR3E, HTR1F MDM2 3600/4885KMT2A 1252/4885TLR2 3697/4885
US-20070208007-A1 Amine-Based Compound and Use Thereof NR0B2, NR5A2, NR2E1 MDM2 4060/4885KMT2A 488/4885TLR2 380/4885
US-20160017000-A1 RGD-CONTAINING CYCLIC PEPTIDES ITGAV, ITGB3, ITGAL MDM2 3687/4885KMT2A 4670/4885TLR2 2085/4885
US-20070149763-A1 Beta secretase exosite binding peptides and methods for identifying beta secretase modulators BACE1, BACE2, APP MDM2 726/4885KMT2A 4054/4885TLR2 4730/4885
US-20230146515-A1 MITOCHONDRIA-TARGETING PEPTIDES HSPE1, TFAM, TNNI3 MDM2 3209/4885KMT2A 4820/4885TLR2 3907/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.